The Pharmacology and Therapeutic Use of β-Adrenergic Receptor Blocking Drugs in Cardiovascular Disease Donald C. Harrison Guest Editorial 27 October 2012 Pages: 1 - 7
Pharmacodynamic Properties of β-Adrenergic Receptor Blocking Drugs in Man D. G. Gibson Review Article 27 October 2012 Pages: 8 - 38
Pharmacokinetic Properties of the β-Adrenergic Receptor Blocking Drugs D. G. Shand Review Article 27 October 2012 Pages: 39 - 47
β-Adrenergic Receptor Blocking Drugs in Hyperthyroidism Paul Turner Review Article 27 October 2012 Pages: 48 - 54
β-Adrenergic Receptor Blocking Drugs in Angina Pectoris B. N. C. Prichard Review Article 27 October 2012 Pages: 55 - 84
β-Adrenergic Receptor Blocking Drugs in Hypertension F. O. Simpson Review Article 27 October 2012 Pages: 85 - 105
β-Adrenergic Receptor Blocking Drugs in Hypertrophic Cardiomyopathy, Autonomically Mediated Cardiovascular Functional Disorders and Fallot’s Tetralogy C. D. Furberg Review Article 27 October 2012 Pages: 106 - 117
Adverse Reactions to β-Adrenergic Receptor Blocking Drugs: A Report from the Boston Collaborative Drug Surveillance Program David J. GreenblattJan Koch-Weser Review Article 27 October 2012 Pages: 118 - 129
Adverse Effects of β-Adrenergic Receptor Blocking Drugs on Respiratory Function Hendrik M. Beumer Review Article 27 October 2012 Pages: 130 - 138
